October 29, 2020

SVIN’s Mission Thrombectomy 2020+ Global Campaign Issues White Paper on Improving Awareness, Accessibility, and Action

October 29, 2020—The Society of Vascular and Interventional Neurology (SVIN) announced that is global campaign, Mission Thrombectomy 2020+ (MT2020+), has issued a white paper, “Mechanical Thrombectomy for Acute Stroke. Building Thrombectomy Systems of Care in Your Region: Why and How”, targeted toward health policymakers. The paper was distributed on October 29 to coincide with World Stroke Day.

According to SVIN, the paper examines the widespread inaccessibility and geographical disparities in receiving mechanical thrombectomy (MT). Interventional MT treatment, which has been proven to be beneficial in multiple large studies across many countries since 2015, needs to be performed within the first 24 hours of symptom onset for disabling large vessel occlusion (LVO) stroke. Its outcomes are highly time-sensitive, especially early on.

SVIN stated that the white paper report calls for sweeping increase in MT awareness, accessibility, and action on a worldwide level. The United States is a global leader in MT patient care, but the burden of care is approximately 4 to 5 times greater in many lower- to middle-income countries.

SVIN Past-President Dileep Yavagal, MD, serves as Chair of MT2020+. Dr. Yavagal stated in the SVIN announcement, “LVO stroke is a long-standing silent global crisis that now has a highly effective solution since the last 5 years: MT. However, thrombectomy care isn’t widely accessible, with colossal geographic disparities on a global level. We are calling on public health policymakers to increase physical, financial, and diagnostic access to thrombectomy for patients with disabling stroke to prevent a lifetime of suffering and death.”

According to MT2020+, the data on stroke patients and the level of care they receive include the following:

  • Approximately 13.67 million people experience strokes worldwide each year
  • 20% to 30% of all ischemic strokes are caused by an LVO stroke, which makes them eligible for highly effective MT treatment
  • Less than 10% of eligible LVO stroke patients receive MT, leaving approximately 2 million people in need of this procedure but unable to receive it

The two main goals set forth by the MT2020+ initiative and detailed in the report are: (1) implement public health interventions to double global access to MT treatments every 2 years for the next decade, and (2) perform 202,000 MT procedures worldwide by the end of 2020.

The white paper also provides perspectives on:

  • Cost-effectiveness of patient care afforded by successful implementation of MT protocols
  • Tracking metrics and analytics made available through the dedicated MT2020+ Global Thrombectomy Tracking app
  • Educational tools for members of the community
  • Training initiatives for emergency medical services and health care professionals
  • Building thrombectomy systems-of-care in the community
  • Improving interhospital transfers for MT patients

The white paper will be disseminated in all six continents by the 82 regional committees of MT2020+. The long-term goal is the emergence and widespread availability of MT as the standard of care globally. Progress has been made since the formation of MT2020+ in 2016, but there is still an imminent need for continued efforts, noted the SVIN announcement.


October 30, 2020

iVascular Acquires the German Distribution Company Endoscout

October 29, 2020

Bendit Technologies Reports Successful FIH Use of Its Steerable Neuro Microcatheter